The ongoing debate regarding the impact of examined lymph node count on staging and long-term survival of resected non-small cell lung cancer: an editorial review

Rian M. Hasson Charles, Shanda H. Blackmon


While lymph node (LN) status continues to be one of the most important predictors of prognosis and survival in patients with potentially resectable lung cancer, controversy still remains regarding what is the optimal technique to assess LNs: sampling versus dissection (1-3).